• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨大良性前列腺增生症:一例报告

Giant Benign Prostatic Hyperplasia: A Case Report.

作者信息

Mdivnishvili Marika, Khuskivadze Nutsa, Khuskivadze Alexandre

机构信息

Cardiac, Thoracic, and Vascular Surgery, Jerarsi Hospital, Tbilisi, GEO.

Cardiology, Tbilisi State Medical University, Tbilisi, GEO.

出版信息

Cureus. 2024 May 29;16(5):e61295. doi: 10.7759/cureus.61295. eCollection 2024 May.

DOI:10.7759/cureus.61295
PMID:38947583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11212843/
Abstract

We present the case of a 69-year-old man experiencing lower urinary tract symptoms (LUTS), notably difficulties with urination. His total prostate-specific antigen level was measured at 3.52 ng/ml, accompanied by an International Prostate Symptom Score of 32. Transrectal ultrasound revealed a prostate volume of 268 cm. Benign prostatic hyperplasia (BPH) is a common condition among aging men, often manifesting as LUTS. However, in rare instances, BPH can progress pathologically to giant prostatic hyperplasia, characterized by a prostate gland exceeding 500 g in weight. This report documents the successful enucleation of the giant BPH without significant complications, utilizing a transvesical prostatectomy technique. Our case underscores the importance of early diagnosis and appropriate management strategies.

摘要

我们报告了一例69岁男性出现下尿路症状(LUTS)的病例,特别是排尿困难。他的总前列腺特异性抗原水平测得为3.52 ng/ml,国际前列腺症状评分32分。经直肠超声显示前列腺体积为268 cm。良性前列腺增生(BPH)是老年男性中的常见病症,常表现为LUTS。然而,在罕见情况下,BPH可病理进展为巨大前列腺增生,其特征为前列腺重量超过500 g。本报告记录了采用经膀胱前列腺切除术技术成功摘除巨大BPH且无明显并发症的情况。我们的病例强调了早期诊断和适当管理策略的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36e/11212843/860d361697ed/cureus-0016-00000061295-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36e/11212843/5731be9a3c3a/cureus-0016-00000061295-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36e/11212843/860d361697ed/cureus-0016-00000061295-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36e/11212843/5731be9a3c3a/cureus-0016-00000061295-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a36e/11212843/860d361697ed/cureus-0016-00000061295-i02.jpg

相似文献

1
Giant Benign Prostatic Hyperplasia: A Case Report.巨大良性前列腺增生症:一例报告
Cureus. 2024 May 29;16(5):e61295. doi: 10.7759/cureus.61295. eCollection 2024 May.
2
Giant benign prostatic hyperplasia: A case report.巨大良性前列腺增生症:一例报告。
Urol Case Rep. 2019 Oct 19;28:101051. doi: 10.1016/j.eucr.2019.101051. eCollection 2020 Jan.
3
Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.经尿道双极等离子前列腺剜除术与开放性前列腺切除术治疗大体积良性前列腺增生症的中期前瞻性随机对照研究。
BJU Int. 2013 May;111(5):793-803. doi: 10.1111/j.1464-410X.2012.11730.x. Epub 2013 Mar 7.
4
[Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].[前列腺、膀胱超声指标及尿流率参数在良性前列腺增生男性膀胱颈梗阻诊断中的应用]
Urologiia. 2017 Oct(5):9-14. doi: 10.18565/urology.2017.5.9-14.
5
Management of a giant prostatic enlargement: Case report and review of the literature.巨大前列腺增生的管理:病例报告及文献综述
Niger Postgrad Med J. 2020 Jul-Sep;27(3):242-247. doi: 10.4103/npmj.npmj_69_20.
6
Holmium laser enucleation of a 696 cc prostate (HoLEP): The largest reported in the literature.钬激光剜除696立方厘米前列腺(HoLEP):文献报道中最大的一例。
Urol Case Rep. 2022 Aug 24;45:102203. doi: 10.1016/j.eucr.2022.102203. eCollection 2022 Nov.
7
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.用于治疗良性前列腺增生的能量输送系统:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 1.
8
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素:克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
9
Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.代谢综合征相关因素对亚洲人群良性前列腺增生和下尿路症状发生发展的影响。
Medicine (Baltimore). 2019 Oct;98(42):e17635. doi: 10.1097/MD.0000000000017635.
10
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.前列腺素途径在接受药物治疗失败的良性前列腺增生症伴下尿路症状患者中被激活。
Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20.

本文引用的文献

1
A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.对良性前列腺增生关键治疗方案的临床、生活质量及成本效益结果的综合分析。
PLoS One. 2022 Apr 15;17(4):e0266824. doi: 10.1371/journal.pone.0266824. eCollection 2022.
2
Management of a giant prostatic enlargement: Case report and review of the literature.巨大前列腺增生的管理:病例报告及文献综述
Niger Postgrad Med J. 2020 Jul-Sep;27(3):242-247. doi: 10.4103/npmj.npmj_69_20.
3
Giant benign prostatic hyperplasia: A case report.
巨大良性前列腺增生症:一例报告。
Urol Case Rep. 2019 Oct 19;28:101051. doi: 10.1016/j.eucr.2019.101051. eCollection 2020 Jan.
4
Androgen action in prostate function and disease.雄激素在前列腺功能和疾病中的作用。
Am J Clin Exp Urol. 2018 Apr 1;6(2):62-77. eCollection 2018.
5
Epidemiology of clinical benign prostatic hyperplasia.临床良性前列腺增生症的流行病学
Asian J Urol. 2017 Jul;4(3):148-151. doi: 10.1016/j.ajur.2017.06.004. Epub 2017 Jun 9.
6
A case of giant prostatic hyperplasia.一例巨大前列腺增生症。
Asian J Urol. 2016 Jan;3(1):53-55. doi: 10.1016/j.ajur.2015.10.004. Epub 2015 Nov 3.
7
Giant Prostatic Hyperplasia: Fourth largest prostate reported in medical literature.巨大前列腺增生:医学文献报道的第四大前列腺病例。
Sultan Qaboos Univ Med J. 2014 May;14(2):e253-6. Epub 2014 Apr 7.
8
Benign prostatic hyperplasia.良性前列腺增生
Lancet. 2003 Apr 19;361(9366):1359-67. doi: 10.1016/S0140-6736(03)13073-5.